Drug Legislation NewsLatest News On Drug Legislation Europe Rejects Cinainu (Alopecia) and Kizfizo (Neuroblastoma)11/15/2024 11:42 AM Leqembi Okayed for Subset of Early Alzheimer’s Patients11/15/2024 10:34 AM Two Lung Cancer Drugs Recommended by EMA11/15/2024 10:34 AM EMA OKs Sublingual Formulation for Opioid Dependence10/18/2024 9:55 AM EMA Authorizes Korjuny for Malignant Ascites10/18/2024 8:41 AM Hympavzi Approved in Europe for Severe Hemophilia A and B9/20/2024 10:43 AM EMA Backs Approval of Elahere for Ovarian Cancer9/20/2024 9:46 AM Two New Drugs Approved for Age-Related Macular Degeneration9/20/2024 9:45 AM Canada Moves Toward 'Agile' Drug, Device Approval8/19/2024 8:08 AM EU OKs First-Line Osimertinib + Chemo for EGFR+ Advanced NSCLC7/5/2024 9:23 AM Europe Endorses Its First mRNA Vaccine for RSV6/28/2024 12:15 PM EMA Greenlights Four Drugs for Bladder and Other Cancers6/28/2024 11:19 AM Pulmonary Arterial Hypertension Drug OK'd by Europe6/28/2024 9:33 AM New Drugs Turned Down by EU Safety Assessor6/28/2024 9:32 AM First Nasal Adrenaline Spray for Anaphylaxis Backed by EMA6/28/2024 8:38 AM Europe Approves Fruzaqla for Metastatic Colorectal Cancer6/27/2024 4:31 AM Severe Hypoglycemia in Diabetes Drug Approved in Europe5/31/2024 2:08 PM EMA Panel Nods to Seven New Cancer Drugs5/31/2024 12:57 PM EMA Authorizes Hemophilia B Gene Therapy5/31/2024 10:35 AM EMA Embarks on Psychedelic Trip5/10/2024 5:57 AM
